Evidence map›Paper›PMID 25154665›Full record

ArticleBiomaterials2014

Uncoupling angiogenesis and inflammation in peripheral artery disease with therapeutic peptide-loaded microgels.

Angela L Zachman, Xintong Wang, Jason M Tucker-Schwartz, Sean T Fitzpatrick, Sue H Lee, Scott A Guelcher, Melissa C Skala, Hak-Joon Sung

Abstract read
In one paragraph

Article in Biomaterials, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Buyang Huanwu Decoction Enhances Revascularization via Akt/GSK3Oxidative medicine and cellular longevity · 2021
    Article
  8. Poly (Lactic-Polymers · 2020
    Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Angela L ZachmanBiomedical Engineering, Vanderbilt University, Nashville, TN 37235, USA.
Xintong WangBiomedical Engineering, Vanderbilt University, Nashville, TN 37235, USA.
Jason M Tucker-SchwartzBiomedical Engineering, Vanderbilt University, Nashville, TN 37235, USA.
Sean T FitzpatrickBiomedical Engineering, Vanderbilt University, Nashville, TN 37235, USA.
Sue H LeeBiomedical Engineering, Vanderbilt University, Nashville, TN 37235, USA.
Scott A GuelcherChemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37235, USA.
Melissa C SkalaBiomedical Engineering, Vanderbilt University, Nashville, TN 37235, USA.
Hak-Joon SungBiomedical Engineering, Vanderbilt University, Nashville, TN 37235, USA. Electronic address: hak-joon.sung@vanderbilt.edu.

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
TRANSGENIC MOUSE/ ES CELL SHARES RESOURCESP60DK020593 · NIDDK · VANDERBILT UNIVERSITY · PI MCGUINNESS, OWEN P · 1986 to 2011
$28.1M
Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Kevin L Schey · 1989 to 2026
$19.6M
THREE-TIERED PREVENTION MODEL TO BETTER SERVE ALL STUDENP30HD015052 · NICHD · VANDERBILT UNIVERSITY · PI DYKENS, ELISABETH MAY · 1985 to 2014
$18.6M
Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
Vanderbilt Mouse Metabolic Phenotyping CenterU2CDK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2016 to 2021
$6.3M
Neurovascular Unit on a Chip: Regional Chemical Communication, Drug and Toxin ResponsesUH3TR000491 · NCATS · VANDERBILT UNIVERSITY · PI GHOSH, CHAITALI, JANIGRO, DAMIR · 2014 to 2016
$3.8M
Neurovascular Unit on a Chip: Chemical Communication, Drug and Toxin ResponsesUH2TR000491 · NCATS · VANDERBILT UNIVERSITY · PI JANIGRO, DAMIR, NISWENDER, KEVIN D · 2012 to 2013
$2.2M
Functional Optical Coherence Tomography for Monitoring Drug Resistance in CancerR00CA142888 · NCI · VANDERBILT UNIVERSITY · PI SKALA, MELISSA CAROLINE · 2010 to 2012
$727k
Optimizing Bioactive Hydrogels to Control Angiogenesis and Inflammation in FunctiR21HL091465 · NHLBI · RUTGERS, THE STATE UNIV OF N.J. · PI KOHN, JOACHIM B. · 2009 to 2010
$425k
NCATS NIH HHS UH2 TR000491NCATS NIH HHS UH3 TR000491NCI NIH HHS CA68485NCI NIH HHS P30 CA068485NEI NIH HHS EY08126NEI NIH HHS P30 EY008126NHLBI NIH HHS HL091465NHLBI NIH HHS R21 HL091465NICHD NIH HHS HD15052NIDDK NIH HHS DK20593NIDDK NIH HHS DK58404NIDDK NIH HHS DK59637NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P30 DK058404NIDDK NIH HHS U24 DK059637
6 · The paper itself

Abstract

Peripheral artery disease (PAD) is characterized by vessel occlusion and ischemia in the limbs. Treatment for PAD with surgical interventions has been showing limited success. Moreover, recent clinical trials with treatment of angiogenic growth factors proved ineffective as increased angiogenesis triggered severe inflammation in a proportionally coupled fashion. Hence, the overarching goal of this research was to address this issue by developing a biomaterial system that enables controlled, dual delivery of pro-angiogenic C16 and anti-inflammatory Ac-SDKP peptides in a minimally-invasive way. To achieve the goal, a peptide-loaded injectable microgel system was developed and tested in a mouse model of PAD. When delivered through multiple, low volume injections, the combination of C16 and Ac-SDKP peptides promoted angiogenesis, muscle regeneration, and perfusion recovery, while minimizing detrimental inflammation. Additionally, this peptide combination regulated inflammatory TNF-α pathways independently of MMP-9 mediated pathways of angiogenesis in vitro, suggesting a potential mechanism by which angiogenic and inflammatory responses can be uncoupled in the context of PAD. This study demonstrates a translatable potential of the dual peptide-loaded injectable microgel system for PAD treatment.

Indexed as

Angiogenesis Inducing AgentsAnimalsAnti-Inflammatory AgentsCell LineDrug CarriersHuman Umbilical Vein Endothelial CellsInflammationInjectionsMatrix Metalloproteinase 9Matrix Metalloproteinase InhibitorsMiceNeovascularization, PhysiologicOligopeptidesPeripheral Arterial DiseasePolyestersTumor Necrosis Factor-alphaAngiogenesis Inducing AgentsAnti-Inflammatory AgentsDrug CarriersgoralatideMatrix Metalloproteinase 9Matrix Metalloproteinase InhibitorsOligopeptidespolycaprolactonePolyestersTumor Necrosis Factor-alphaAngiogenesisInflammationPeptidePolycaprolactonePolyethylene glycolPolymer

Identifiers

PMID25154665
PMCPMC4164579

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.